Bedside blood infection test being developed for sepsis

Blood poisoning (sepsis) is fast and frightening, and is one of the leading causes of death worldwide, killing up to half of its victims. Therefore, a bedside blood test, being developed by British researchers at the University of Liverpool, could allow early treatment, improving the outcomes and maybe even saving lives. Using a biomarker already validated by the group, the researchers are working with Sepsis Limited, a Liverpool-based company, to develop a rapid and robust point-of-care test that uses a drop of blood. The Technology Strategy Board (TSB) is supporting the £1.2 million (about $1.9 million) project. There are no reliable and rapid tests for sepsis, and as Dr. Enitan Carrol, from the University's Institute of Translational Medicine, said: "We want to help doctors make the appropriate clinical decision at the bedside, without having to wait for results from a laboratory." Release

Suggested Articles

A decade-long study found that patients with early breast cancer may be spared radiation procedures that span the whole breast.

A cell therapy for Parkinson’s disease starts out simple, but quickly gets complicated with the potential for immune responses and cancer mutations.

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.